Page last updated: 2024-08-23

nafazatrom and Pituitary Neoplasms

nafazatrom has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjøro, T; Englund, K; Haug, E; Torjesen, PA1
Judd, AM; Koike, K; Login, IS; MacLeod, RM; Yasumoto, T1

Other Studies

2 other study(ies) available for nafazatrom and Pituitary Neoplasms

ArticleYear
Inhibitors of the arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated prolactin production without modifying the production of inositolphosphates in GH4C1 pituitary cells.
    Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Inositol Phosphates; Lipoprotein Lipase; Lipoxygenase Inhibitors; Phospholipases A; Phospholipases A2; Pituitary Neoplasms; Prolactin; Pyrazoles; Pyrazolones; Quinacrine; Rats; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured

1993
Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
    Neuroendocrinology, 1986, Volume: 43, Issue:3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Indomethacin; Ion Channels; Marine Toxins; Oxocins; Pituitary Neoplasms; Prolactin; Prostaglandins; Pyrazoles; Pyrazolones; Rats; SRS-A

1986